C.M.D. v. HHS - DTaP, chronic immune thrombocytopenia purpura (ITP) (2024)

Nicholas and Krystal Delaney, parents and guardians of C.M.D., filed a petition for compensation under the National Vaccine Injury Compensation Program on July 27, 2021. They alleged that their minor child, C.M.D., suffered chronic immune thrombocytopenia purpura (ITP) as a result of receiving the diphtheria-tetanus-acellular-pertussis (DTaP), Hepatitis B (Hep B), inactivated poliovirus (IPV), and/or pneumococcal conjugate (PCV-13) vaccines on July 27, 2018.

Petitioners further alleged that C.M.D. experienced residual effects of this condition for more than six months. The respondent denied that the DTaP, Hep B, IPV, and/or PCV-13 vaccines caused C.M.D.'s ITP or its residual effects, or any other injury.

Despite maintaining their positions, both parties agreed to settle the case through a stipulation filed on December 3, 2024. Chief Special Master Brian H.

Corcoran reviewed the file and adopted the stipulation as the decision. The stipulation awarded a lump sum of $50,000.00 payable to Petitioners as guardians/conservators of C.M.D.'s estate and a lump sum of $1,658.19 payable to Petitioners, totaling $51,658.19 for all damages.

The public decision does not describe the onset of symptoms, specific medical tests, treatments, or the mechanism of causation. Petitioner counsel was Kathleen M.

Loucks, and respondent counsel was Bridget Corridon.